Searching the RRID Resource Information Network
Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
SciCrunch Registry is a curated repository of scientific resources, with a focus on biomedical resources, including tools, databases, and core facilities - visit SciCrunch to register your resource.
| Resource Name | Proper Citation | Abbreviations | Resource Type |
Description |
Keywords | Resource Relationships | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
National Genome Research Network Resource Report Resource Website 10+ mentions |
National Genome Research Network (RRID:SCR_006626) | NGFN | data or information resource, organization portal, portal | The program of medical genome research is a large-scale biomedical research project which extends the national genome research net (NGFN) and will be funded by the federal ministry of education and research (BMBF) from 2008-2013. Currently the program includes two fields: * Research ** NGFN-Plus: With the aim on combating diseases that are central to health policy, several hundred researchers are systematically investigating the complex molecular interactions of the human body. They are organized in 26 Integrated Genome Research Networks. * Application ** NGFN-Transfer: The rapid transfer of results from medical genome research into medical and industrial application is the aim of the scientists from research institutes and biomedical enterprises that cooperate in eight Innovation Alliances. AREAS OF DISEASE * Cardiovascular disease * Cancer * Neuronal diseases * Infections and Inflammations * Environmental factors | genome, research, gene, disease | Cardiovascular disease, Cancer, Neuronal disease, Infectious disease, Inflammation, Disease linked to environment | BMBF | nlx_151595 | SCR_006626 | NGFN - National Genome Research Network, German National Genome Research Network | 2026-09-12 01:00:57 | 26 | |||||||
|
Central England Haemato-Oncology Research Biobank Resource Report Resource Website |
Central England Haemato-Oncology Research Biobank (RRID:SCR_004637) | CEHRB | biomaterial supply resource, cell repository, material resource | The Central England Haemato-Oncology Research Biobank stores excess material from oncology samples referred for diagnostic testing and disease monitoring at the West Midlands Regional Genetics Laboratory (WMRGL). The bank is housed within the WMRGL. Types of material stored include viable cells, fixed cell suspensions, DNA, RNA / cDNA, and plasma. The material is made available to all cancer research groups both locally and nationally. Excess sample (mainly from blood and bone marrow) is stored from diagnostic patient material and from samples received throughout their disease course. The WMRGL serves a population of about 5.5 million and is the largest UK NHS genetic Lab. Due to the large patient population CEHRB is able to collate sufficient research material from all classifications of neoplastic haematological disorders including those that are rare. | rare, ontology, hematology, tumor, oncology | is listed by: One Mind Biospecimen Bank Listing | Cancer, Neoplastic hematological disorder | Public: The material is made available to all cancer research groups both locally and nationally. | nlx_63387 | http://www.bwhct.nhs.uk/genetics-index/reglab_oncology.htm, http://www.bwhct.nhs.uk/genetics-index/central_england_haemato-oncology_research_biobank.htm | SCR_004637 | Central England Haemato-Oncology Research Biobank (CEHRB) | 2026-09-12 01:00:55 | 0 | |||||
|
Wistar Institute Collection at Coriell Resource Report Resource Website |
Wistar Institute Collection at Coriell (RRID:SCR_004660) | Wistar Collection | biomaterial supply resource, cell repository, material resource | Collection of cell lines developed by Wistar scientists that includes a group of hybridomas that produce monoclonal antibodies that are useful in influenza research and vaccine development, melanoma cell lines derived from patients with diseases ranging from mild dysplasia to advanced metastatic cancer and a range of human endothelial cell lines. | hybridoma, monoclonal antibody, antibody, cell line, melanoma cell line, endothelial cell line, smooth muscle cell line, disease, cancer, dysplasia, metastatic cancer |
is listed by: One Mind Biospecimen Bank Listing has parent organization: Coriell Cell Repositories has parent organization: Wistar Institute |
Disease, Cancer, Dysplasia, ( Diseases ranging from mild dysplasia to advanced metastatic cancer ) | Non-commercial, For research conducted by universities, Government agencies and academic research centers, Commercial with license | nlx_143856 | SCR_004660 | 2026-09-12 01:00:55 | 0 | |||||||
|
Australia Breast Cancer Tissue Bank Resource Report Resource Website |
Australia Breast Cancer Tissue Bank (RRID:SCR_000926) | ABCTB | biomaterial supply resource, material resource | A tissue bank which houses and supplies cancerous tissue for use by the research community. Along with tissue, the bank collects clinical history, lifestyle factors, breast pathology, treatment information, and follow up information. | cancer, tissue bank, breast, tissue, human, clinical history, treatment information, pathology | Cancer | National Health and Medical Research Council of Australia ; National Breast Cancer Foundation ; Cancer Institute of NSW |
THIS RESOURCE IS NO LONGER IN SERVICE | nlx_54620 | SCR_000926 | 2026-09-12 01:02:25 | 0 | |||||||
|
TARGETgene Resource Report Resource Website 1+ mentions |
TARGETgene (RRID:SCR_001392) | TARGETgene | software application, software resource | MATLAB tool to effectively identify potential therapeutic targets and drugs in cancer using genetic network-based approaches. It can rapidly extract genetic interactions from a precompiled database stored as a MATLAB MAT-file without the need to interrogate remote SQL databases. Millions of interactions involving thousands of candidate genes can be mapped to the genetic network within minutes. While TARGETgene is currently based on the gene network reported in (Wu et al.,Bioinformatics 26:807-813, 2010), it can be easily extended to allow the optional use of other developed gene networks. The simple graphical user interface also enables rapid, intuitive mapping and analysis of therapeutic targets at the systems level. By mapping predictions to drug-target information, TARGETgene may be used as an initial drug screening tool that identifies compounds for further evaluation. In addition, TARGETgene is expected to be applicable to identify potential therapeutic targets for any type or subtype of cancers, even those rare cancers that are not genetically recognized. Identification of Potential Therapeutic Targets * Prioritize potential therapeutic targets from thousands of candidate genes generated from high-throughput experiments using network-based metrics * Validate predictions (prioritization) using user-defined benchmark genes and curated cancer genes * Explore biologic information of selected targets through external databases (e.g., NCBI Entrez Gene) and gene function enrichment analysis Initial Drug Screening * Identify for further evaluation existing drugs and compounds that may act on the potential therapeutic targets identified by TARGETgene * Explore general information on identified drugs of interest through several external links Operating System: Windows XP / Vista / 7 | disease target, drug discovery, drug, matlab, gene network, genetic interaction, gene, drug screening, mutation driver, therapeutic target, drug candidate, compound, mapping, analysis | has parent organization: Biomedical Simulations Resource | Cancer | NIBIB P41-EB001978 | PMID:22952662 | Free, Under the terms of a Release Agreement., Please cite | nlx_152573 | http://bmsr.usc.edu/Software/TARGET/TARGET.html | SCR_001392 | 2026-09-12 01:02:26 | 8 | ||||
|
Roswell Park Data Bank and BioRepository Resource Report Resource Website |
Roswell Park Data Bank and BioRepository (RRID:SCR_003607) | DBBR | biomaterial supply resource, material resource | Collects and provides de-identified biospecimens and associated epidemiological and clinical data to meet the scientific needs of investigators. Newly diagnosed patients are asked to contribute data and specimens to the DBBR prior to treatment. Other patients with who have benign disease or advanced disease and have undergone treatment are also enrolled based on anticipated use of data and samples for research. Additionally, non-patients (family members and friends of patients and community members) with no personal history of cancer are asked to participate in the biorepository as controls. Specimens and data are procured with protected health information (PHI) and de-identified prior to distribution to investigators with hypothesis driven IRB reviewed studies. An extensive data collection and management system is in place to track informed consent, questionnaire collection and follow up, epidemiological questionnaire data, clinical data, biospecimens and their derivatives. Research Services * Availability of a bank of prospectively collected blood specimens (serum, plasma, buffy coat, red blood cells and DNA) from cancer patients, high risk individuals and healthy controls for research. * Collection, linking and distribution of epidemiologic and clinical data with biospecimens. * Study-specific biospecimen and data procurement to meet the needs of individual studies, including: ** Participant identification, eligibility screening and informed consent ** Serial biospecimen procurement prior to and throughout treatment ** Study specific collection of biospecimens other than blood (buccal cells, sputum, and urine) ** Procurement and distribution of fresh biospecimens ** Collection of extended clinical and risk factor data | clinical data, epidemiologic data, cancer, control, benign cancer disease, advanced cancer, blood, serum, plasma, buffy coat, red blood cell, dna, high risk individual, healthy control, buccal cell, sputum, urine |
is listed by: One Mind Biospecimen Bank Listing has parent organization: Roswell Park Comprehensive Cancer Center |
Cancer, Control, Benign cancer, Advanced cancer, High risk individual, Healthy control | nlx_13096 | http://www.roswellpark.org/Prevention/Data_Bank_and_BioRepository | SCR_003607 | Roswell Park Cancer Institute DataBank and BioRepository, Roswell Park Cancer Institute Data Bank BioRepository, RPCI Data Bank BioRepository, Roswell Park Cancer Institute Data Bank and BioRepository, RPCI DataBank and BioRepository, RPCI DBBR, RPCI Data Bank and BioRepository, Roswell Park DataBank and BioRepository, Roswell Park Data Bank BioRepository | 2026-09-12 01:02:30 | 0 | ||||||
|
Nuclear Receptor Signaling Atlas Resource Report Resource Website 100+ mentions |
Nuclear Receptor Signaling Atlas (RRID:SCR_003287) | NURSA | biomaterial supply resource, material resource | THIS RESOURCE IS NO LONGER IN SERVICE.Documented on February 25, 2022.Software tool as knowledge environment resource that accrues, develops, and communicates information that advances understanding of structure, function, and role in disease of nuclear receptors (NRs) and coregulators. It specifically seeks to elucidate roles played by NRs and coregulators in metabolism and development of metabolic disorders. Includes large validated data sets, access to reagents, new findings, library of annotated prior publications in field, and journal covering reviews and techniques.As of March 20, 2020, NURSA is succeeded by the Signaling Pathways Project (SPP). | nuclear receptor, coregulator, metabolism, metabolic disorder, type 2 diabetes, obesity, osteoporosis, lipid dysregulation, cardiovascular disease, oncology, regenerative medicine, environmental agent, genomics, proteomics, reagent, ligand, microarray, gene expression, data set, data analysis service, nuclear receptor signaling, signaling, high through put screening, receptor, ligand, journal, molecule, affinity purification, q-pcr, chip-chip, animal model, antibody, cell line, primer, transcriptomine, clinical trial, disease, drug, data set |
is used by: NIF Data Federation is used by: NIDDK Information Network (dkNET) is recommended by: National Library of Medicine lists: NURSA Transcriptomine lists: STRING lists: Nuclear Receptor Cistrome is listed by: NIH Data Sharing Repositories is listed by: NIDDK Research Resources is listed by: NIDDK Information Network (dkNET) is related to: dkCOIN is related to: Integrated Manually Extracted Annotation has parent organization: Baylor College of Medicine; Houston; Texas |
Metabolic disorder, Type 2 diabetes mellitus, Obesity, Osteoporosis, Lipid dysregulation, Cardiovascular disease, Diabetes, Cancer | NHLBI ; NICHD ; NIDDK DK097748; NIEHS |
DOI:10.1101/401729 | Free, Freely available | nif-0000-03208 | https://dknet.org/about/NURSA_Archive | http://www.nursa.org | SCR_003287 | NURSA - Nuclear Receptor Signaling Atlas, NURSA - The Nuclear Receptor Signaling Atlas | 2026-09-12 01:02:29 | 135 | ||
|
Biobank Graz Resource Report Resource Website |
Biobank Graz (RRID:SCR_004245) | Biobank Graz | biomaterial supply resource, material resource | Biobank Graz is a non-profit central Medical University of Graz (MUG) service facility that provides the logistics and infrastructure to optimally support MUG research teams in the collection, processing and storage of biological samples and their associated data. In the course of this, special attention is given to sample and data quality and to the protection of the individual rights of patients. Samples from selected patients at the Graz LKH-University Clinical Centre, who have signed an informed consent declaration, are deposited in Biobank Graz. This means that excess tissue and blood samples are collected and placed in storage. The samples are harvested in the course of routine interventions undertaken by the different departments and institutes of the Graz LKH-University Clinical Centre and approved for use in research projects only after the completion of all necessary laboratory and histopathological analyses. No additional material is removed: in other words, there are no associated drawbacks whatsoever for the patients involved. Biobank Graz operates a quality management system according to ISO 9001:2008 and offers the following services for the processing and storage of biological samples and the handling of data: * Consistently high sample quality through the processing of samples using standardized methods in accordance with written working instructions (SOPs) * Efficient use of resources through the building of shared infrastructure and the development of optimized processes * A high degree of reliability provided by the storage of samples in 24/7 - monitored storage systems. * Processing and storage of all data in accordance with data protection legislation. Biobank Graz comprises both population-based and disease-focused collections of biological materials. It currently contains approx. 3.8 mio samples from approx. 1.2 mio patients representing a nonselected patient group characteristic of central Europe. Because the Institute of Pathology was, until 2003, the exclusive pathology service provider for major parts of the province of Styria, including its capital Graz (population approx. 1.2 mio people), samples from all human diseases, treated by surgery or diagnosed by biopsy, are included in the collection at their natural frequency of occurrence and thus represent cancers and non-cancerous diseases from all organs, and from all age groups. The scientific value of the existing tissue collection is, thus, not only determined by its size and technical homogeneity (all samples have been processed in a single institute under constant conditions for more than 20 years), but also by its population-based character. These features provide ideal opportunities for epidemiological studies and allow the validation of biomarkers for the identification of specific diseases and determination of their response to treatment. Prospectively collected tissues, blood samples and clinical data comprise, on the one hand, randomly selected samples from all diseases and patient groups to provide sufficient numbers of samples for the evaluation of the disease-specificity of any gene or biomarker. On the other hand, Biobank Graz adopts a disease-focused approach for selected diseases (such as breast, colon and liver cancers as well as some metabolic diseases) through the collection of a range of different human biological samples of highest quality and detailed clinical follow-up data. Graz Medical University established the Biobank to provide improved and sustainable access to biological samples and related (clinical) data both for its own academic research and for external research projects of academic and industrial partners. It is a major interest of the university to initiate co-operative research projects. Biological samples and data are available to external institutions performing high-quality research projects which comply with the Biobank''s ethical and legal framework according to the access rules (Contact: COO Karine Sargsyan, MD, PhD). | tissue, blood, dna, rna, serum, plasma, bodily fluid, urine, cryopreserved, formalin fixed paraffin embedded, csf, frozen, disease, population, patient, healthy, normal, clinical, patient, healthy, normal, disease, cancer, metabolic disease, breast cancer, colon cancer, liver cancer, clinical data, cerebral spinal fluid |
is listed by: One Mind Biospecimen Bank Listing has parent organization: Medical University of Graz; Graz; Austria |
All, Patient, Healthy, Normal, Disease, Cancer, Metabolic disease, Breast cancer, Colon cancer, Liver cancer | Public: Graz Medical University established the Biobank to provide improved and sustainable access to biological samples and related (clinical) data both for its own academic research and for external research projects of academic and industrial partners. It is a major interest of the university to initiate co-operative research projects. Biological samples and data are available to external institutions performing high-quality research projects which comply with the Biobank''s ethical and legal framework according to the access rules. | nlx_25894 | SCR_004245 | 2026-09-12 01:02:32 | 0 | |||||||
|
Fred Hutchinson Cancer Research Center Co-operative Center for Excellence in Hematology Resource Report Resource Website |
Fred Hutchinson Cancer Research Center Co-operative Center for Excellence in Hematology (RRID:SCR_015320) | data or information resource, organization portal, portal | THIS RESOURCE IS NO LONGER IN SERVICE. Documented on July,27,2022. Core facility that provides scientific and budgetary oversight for all CCEH activities. This includes training programs, high school summer internships, and and pilot and feasibility program for new projects. | cancer research, administrative support, budgetary oversight, training programs |
is listed by: NIDDK Information Network (dkNET) has parent organization: Fred Hutchinson Cancer Center has organization facet: Fred Hutchinson Cancer Research Center Co-operative Center for Excellence in Hematology Antibody Technology has organization facet: Fred Hutchinson Cancer Research Center Co-operative Center for Excellence in Hematology Arnold Library has organization facet: Fred Hutchinson Cancer Research Center Co-operative Center for Excellence in Hematology Bioinformatics Resource has organization facet: Fred Hutchinson Cancer Research Center Co-operative Center for Excellence in Hematology Comparative Medicine has organization facet: Fred Hutchinson Cancer Research Center Co-operative Center for Excellence in Hematology Electron Microscopy has organization facet: Fred Hutchinson Cancer Research Center Co-operative Center for Excellence in Hematology Experimental Histopathology Shared Resource has organization facet: Fred Hutchinson Cancer Research Center Co-operative Center for Excellence in Hematology Flow Cytometry has organization facet: Fred Hutchinson Cancer Research Center Co-operative Center for Excellence in Hematology Genomics Shared Resource has organization facet: Fred Hutchinson Cancer Research Center Co-operative Center for Excellence in Hematology Glassware Services has organization facet: Fred Hutchinson Cancer Research Center Co-operative Center for Excellence in Hematology Proteomics Resource has organization facet: Fred Hutchinson Cancer Research Center Co-operative Center for Excellence in Hematology Research Freezers and Sample Storage Resource has organization facet: Fred Hutchinson Cancer Research Center Co-operative Center for Excellence in Hematology Scientific Imaging has organization facet: Fred Hutchinson Cancer Research Center Co-operative Center for Excellence in Hematology Specimen Processing/Research Cell Bank is organization facet of: Hematology Centers |
cancer | NIDDK P30DK056465 | THIS RESOURCE IS NO LONGER IN SERVICE | SCR_015922 | SCR_015320 | 2026-09-12 01:01:03 | 0 | |||||||
|
Biorepositories and Biospecimens Research Branch Resource Report Resource Website 1+ mentions |
Biorepositories and Biospecimens Research Branch (RRID:SCR_013979) | data or information resource, portal | BBRB supports medical discovery and precision medicine by providing leadership, tools, and resources to the biobanking community. Provides input on policy related to biobanking and supports the availability of biospecimens for research. Develops standardized procedures for biospecimen science and research; conducts and sponsors research on the effects of biospecimen preanalytical factors; leads and supports major scientific initiatives requiring high-quality biospecimens; and supports investigations into the ethical, legal, and social issues concerning biospecimen collection and use. | portal, biospecimen, human biospecimen, cancer, cancer research, database, |
is listed by: Connected Researchers is related to: Biospecimen Research Database is related to: caHUB is related to: Connected Researchers has parent organization: National Cancer Institute |
cancer | Free, Freely available | http://biospecimens.cancer.gov/default.asp | SCR_013979 | , NCI’s Biorepositories and Biospecimen Research Branch (BBRB) | 2026-09-12 01:01:01 | 1 | |||||||
|
La Jolla Institute for Immunology Resource Report Resource Website |
La Jolla Institute for Immunology (RRID:SCR_014837) | LJI, | data or information resource, organization portal, portal | Non profit collaborative research organization located in La Jolla, California, UCSD Research Park. Institute researches immunology and immune system diseases to pinpoint specific genes involved, accelerate progress toward development of new treatments and vaccines to prevent and cure type 1 diabetes, cancer and infectious disease. Developer of Immune Epitope Database (IEDB). Provides core facilities with access to equipment, technologies, training and expertise to support innovative research. | Immunology, vaccine, infectious disease, immune system, Immune Epitope Database, sequencing, high throughput, bioinformatics |
is related to: Coronavirus Immunotherapy Consortium is parent organization of: Database of Immune Cell Epigenomes is parent organization of: La Jolla Institute for Immunology Next Generation Sequencing Core Facility is organization facet of: Immune Epitope Database and Analysis Resource (IEDB) |
Type 1 diabetes, Diabetes, Allergy, Alzheimer's disease, Asthma, Atherosclerosis, Atopic dermatitis, Eczema, Autoimmune disease, Cancer, COVID-19, Dengue, Ebola, Fibrosis, Food allergies, HIV, Imflammatory bowel disease, Japanese encephalitis, Lassa fever, Lung cancer, Multiple sclerosis, Nipah, Parkinson's disease, Pneumonia | SCR_014837 | LJI, la jolla, Institute for immunology, La Jolla Institute for Allergy and Immunology | 2026-09-12 01:01:03 | 0 | ||||||||
|
Cancer Imaging Phenomics Toolkit Resource Report Resource Website 10+ mentions |
Cancer Imaging Phenomics Toolkit (RRID:SCR_017323) | CaPTk | data processing software, image analysis software, software application, software resource | Software platform for analysis of radiographic cancer images. Used as quantitative imaging analytics for precision diagnostics and predictive modeling of clinical outcome. | analysis, radiographic, cancer, image, quantitative, analytics | is related to: University of Pennsylvania Perelman School of Medicine; Pennsylvania; USA | Cancer | NCI U24 CA189523 | PMID:29340286 | Free, Available for download, Freely available | https://github.com/CBICA/CaPTk/ | SCR_017323 | Cancer Imaging Phenomics Toolkit | 2026-09-12 01:01:05 | 11 | ||||
|
Harvard Medical School Center for Cancer Systems Pharmacology Resource Report Resource Website |
Harvard Medical School Center for Cancer Systems Pharmacology (RRID:SCR_022831) | CCSP | data or information resource, organization portal, portal | Center includes studies for responsiveness and resistance to anti cancer drugs. Committed to training students and postdocs, promoting junior faculty and ensuring that data and software are reproducible, reliable and publicly accessible. Member of National Cancer Institute’s Cancer Systems Biology Consortium. | anti cancer drugs, responsiveness and resistance, National Cancer Institute, Systems Biology Consortium. | has parent organization: Harvard University; Cambridge; United States | Cancer, Melanoma, Triple negative breast cancer (TNBC), Glioblastoma multiforme (GBM) | NCI U54 CA225088 | Free, Freely available | SCR_022831 | Center for Cancer Systems Pharmacology | 2026-09-12 01:01:11 | 0 | ||||||
|
Creative Biogene Mitochondrial Gene Mutations Resource Report Resource Website |
Creative Biogene Mitochondrial Gene Mutations (RRID:SCR_022082) | data or information resource, organization portal, portal, service resource | Creative Biogene provides comprehensive range of services and products to assist researchers in cancer related mitochondria studies. Offers tests and services with advantage of cell based and animal based models. | Mitochondrial gene mutations, Creative Biogene, cancer related mitochondria studies | cancer | Restricted | SCR_022082 | 2026-09-12 01:01:11 | 0 | ||||||||||
|
Laser Biomedical Research Center Resource Report Resource Website 1+ mentions |
Laser Biomedical Research Center (RRID:SCR_000106) | LBRC | access service resource, biomedical technology research center, service resource | THIS RESOURCE IS NO LONGER IN SERVICE. Documented on July 31,2025. Biomedical technology research center that develops basic scientific understanding and new techniques required for advancing clinical applications of lasers and spectroscopy. LBRC merges optical spectroscopy, imaging, scattering, and interferometry techniques to study biophysics and biochemistry of healthy and diseased biological structures from subcellular to entire-organ scale. | spectroscopy, laser, biomedicine, optical spectroscopy, imaging, scattering, interferometry, optical probe, microscopy | has parent organization: Massachusetts Institute of Technology; Massachusetts; USA; | Pre-cancer, Cancer, Atherosclerosis, Healthy, Diseased | NIBIB 4P41EB015871-30 | THIS RESOURCE IS NO LONGER IN SERVICE | nlx_152645 | SCR_000106 | MIT Laser Biomedical Research Center, Laser Biomedical Research Center (LBRC) | 2026-09-12 01:03:09 | 4 | |||||
|
Human Tumor Atlas Network Resource Report Resource Website 10+ mentions |
Human Tumor Atlas Network (RRID:SCR_023364) | HTAN | atlas, data or information resource, disease-related portal, portal, topical portal | HTAN is National Cancer Institute funded Cancer Moonshot initiative to construct 3-dimensional atlases of dynamic cellular, morphological, and molecular features of human cancers as they evolve from precancerous lesions to advanced disease.Provides three dimensional atlases of cancer transitions for diverse set of tumor types. Efforts to map healthy organs and previous large-scale cancer genomics approaches focused on bulk sequencing at single point in time. Data portal for Human Tumor Atlas Network. Data available on HTAN Portal is open access. Certain data types with potential for re-identification are available in restricted access through dbGAP. | Three dimensional atlases, cancer transitions, diverse set of tumor types, map healthy organs, cancer genomics approaches, bulk sequencing at single point in time, data, precancerous lesions to advanced disease, | cancer | National Cancer Institut Cancer Moonshot Initiative | PMID:32302568 | Free, Freely available | SCR_023364 | 2026-09-12 01:00:38 | 42 | |||||||
|
CancerModels.Org Resource Report Resource Website 1+ mentions |
CancerModels.Org (RRID:SCR_023931) | data or information resource, data repository, disease-related portal, portal, service resource, storage service resource, topical portal | Cancer research platform that aggregates clinical, genomic and functional data from various types of patient derived cancer models, xenographs, organoids and cell lines. Open catalog of harmonised patient-derived cancer models. Standardises, harmonises and integrates clinical metadata, molecular and treatment-based data from academic and commercial providers worldwide. Data is FAIR and underpins generation and testing of new hypotheses in cancer mechanisms and personalised medicine development. PDCM Finder have expanded to organoids and cell lines and is now called CancerModels.Org. PDCM Finder was launched in April 2022 as successor of PDX Finder portal, which focused solely on patient-derived xenograft models. | FAIR data, clinical data, genomic data, functional data, patient derived, cancer models, xenographs, organoids, cell lines, | cancer | NCI R01 CA089713; NCI U24 CA204781 01; NCI U24 CA253539 01 |
PMID:36399494 | Free, Freely available | r3d100012961 | https://doi.org/10.17616/R31NJMHT | SCR_023931 | PDCM Finder, PDX Finder | 2026-09-12 01:00:44 | 8 | |||||
|
Health Information National Trends Survey Resource Report Resource Website 50+ mentions |
Health Information National Trends Survey (RRID:SCR_023943) | HINTS | data or information resource, disease-related portal, portal, topical portal | Regularly collects nationally representative data about American public’s knowledge of, attitudes toward, and use of cancer and health related information. HINTS data are used to monitor changes in fields of health communication and health information technology and to create more effective health communication strategies across different populations. Weighted, nationally representative probability based survey of civilian, non-institutionalized adults administered by National Cancer Institute on knowledge of and attitudes toward cancer relevant information. | National Cancer Institute, HINTS data, American public’s knowledge, cancer relevant information, use of cancer and health related information, survey of civilian and non-institutionalized adults, | cancer | Free, Freely available | SCR_023943 | Health Information National Trends Survey (HINTS), The Health Information National Trends Survey (HINTS) | 2026-09-12 01:00:44 | 52 | ||||||||
|
Cancer Information Service Resource Report Resource Website 1+ mentions |
Cancer Information Service (RRID:SCR_024445) | data or information resource, disease-related portal, portal, topical portal | Portal provides information on Cancer Statistics in Japan. Official website operated by National Cancer Center for cancer information. | Cancer statistics in Japan, National Cancer Center, cancer information, | cancer | Free, Freely available | SCR_024445 | Cancer Information Service in Japan | 2026-09-12 01:00:47 | 1 | |||||||||
|
NCI SEER Cancer Statistics Review Resource Report Resource Website 500+ mentions |
NCI SEER Cancer Statistics Review (RRID:SCR_024685) | data or information resource, disease-related portal, portal, topical portal | Platform to report outlining trends in cancer statistics and methods to derive various cancer statistics from the Surveillance, Epidemiology, and End Results (SEER) program. Authoritative source for cancer statistics in the United States. | trends in cancer, cancer statistics, methods to derive various cancer statistics, Surveillance, Epidemiology, and End Results program, SEER program, | cancer | NCI | Free, Freely available | https://seer.cancer.gov/ | SCR_024685 | SEER Cancer Statistics Review, , National Cancer Institute SEER Cancer Statistics Review, NIH NCI Surveillance, Epidemiology, and End Results Cancer Statistics Review, NIH NCI SEER Cancer Statistics Review | 2026-09-12 01:00:50 | 760 |
Can't find your Tool?
We recommend that you click next to the search bar to check some helpful tips on searches and refine your search firstly. Alternatively, please register your tool with the SciCrunch Registry by adding a little information to a web form, logging in will enable users to create a provisional RRID, but it not required to submit.
Welcome to the RRID Resources search. From here you can search through a compilation of resources used by RRID and see how data is organized within our community.
You are currently on the Community Resources tab looking through categories and sources that RRID has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.
If you have an account on RRID then you can log in from here to get additional features in RRID such as Collections, Saved Searches, and managing Resources.
Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:
If you are logged into RRID you can add data records to your collections to create custom spreadsheets across multiple sources of data.
Here are the facets that you can filter the data by.
If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.
